New Guidelines for Specific Insomnia Drugs to Treat Chronic Insomnia Disorder

Guidelines were found to provide clinical recommendations which help clinicians to choose specific drugs for the treatment of chronic insomnia disorder.

Highlights

Insomnia is one of the most common sleep disorders in the world.
The American Academy of Sleep Medicine issues new guidelines that provide clinical recommendations for specific insomnia drugs to treat chronic insomnia disorder.
Clinicians must consider the recommendations and take proper judgements while deciding drugs for insomnia patients.

The American Academy of Sleep Medicine is the first to issue new clinical guidelines to provide comprehensive, evidence-based analysis of drugs which are used in the treatment of chronic insomnia disorder.

The guidelines were published in the Journal of Clinical Sleep Medicine, which provides recommendations that help clinicians to choose pharmacological agents for the treatment of insomnia in adults.

Interesting Facts and Statistics on Insomnia
Do you have trouble sleeping and are you restless due to sleepless nights? Insomnia is the most common sleeping disorder and it is important to know about its risks.

‘The American Academy of Sleep Medicine issues new recommendations that help clinicians to choose specific drugs for the treatment of chronic insomnia.’

The guidelines which were based on a systematic literature review, meta-analyses, assessment of evidence using GRADE methodology was developed by an expert task force and was approved by the board of directors from American Academy of Sleep Medicine.

President Ronald D. Chervin, MD, MS, said, "The publication of this clinical practice guideline is an important step forward for the field of sleep medicine."

"It further equips clinicians to provide high quality, patient-centered care for millions of people who suffer from chronic insomnia."

Insomnia — Overview
Difficulty in initiating and maintaining sleep is known as insomnia. It is a symptom that occurs due to other disorders and can cause daytime sleepiness.

According to the Centers for the Disease Control and Prevention, an estimated 4.1% of the U.S. adults were found to take a prescription sleep aid in the past month based on the survey data which was collected from 2005-2010.

New Recommendations
The clinical guidelines included 14 specific recommendations for specific insomnia drugs which also included

Insomnia | Sleeping Difficulty - Symptom Evaluation
Insomnia may be due to physiological, psychological, physical or environmental factors. Insomnia should be treated promptly in order to improve the quality of life and prevent other health problems.

Prescription medications - zolpidem and eszopiclone
Over-the-counter medications - diphenhydramine
Dietary supplements - melatonin and valerian

The recommendations were found to suggest whether clinicians may or may not use the drug for sleep onset insomnia versus no treatment.

These guidelines may not however recommend one drug over another even though few comparative studies were carried out on the efficacy.

Sleeping Disorders
How many times have you stayed awake in the dead of the night counting sheep? If it is fairly often then you could be suffering from a sleep disorder!

The authors also found that the data available to support the recommendations are often less than certain and therefore the strength of the recommendations may be weak. This may reflect a lower degree of certainty which may affect on the appropriateness of patient care strategy.

Clinicians must take proper judgements while providing care for patients with insomnia. The decisions are not only based on the recommendations but also on the experience and circumstances of the patients.

The medications for chronic insomnia disorder are mainly considered in patients who are unable to take part in cognitive behavioral therapy for insomnia (CBT-I). The patients who have symptoms even after therapy are those who require temporary adjunct to CBT-I.

The clinical guidelines previously published by the American Academy of Sleep Medicine showed CBT-I to be an effective treatment for insomnia initially. This was repeated in the American Academy of Sleep Medicine in a 2014 Choosing Wisley statement.

Insomnia
Insomnia is caused by certain medical conditions, unhealthy sleep habits, specific substances or biological factors or psychiatric conditions like depression.

Insomnia is a symptom of an underlying sleep disorder like restless sleep disorder, sleep apnea.

Two types of Insomnia
Short-term insomnia - This type of insomnia occur for up to three months. And may affect 15-20% of people.

Chronic insomnia - This type of insomnia occur three times per week and may last for more than 3 months. 10% of the people are found to have chronic insomnia.

References

Michael J. Sateia et al, Clinical Practice Guideline for the Pharmacologic Treatment of Chronic Insomnia in Adults: An American Academy of Sleep Medicine Clinical Practice Guideline, Journal of Clinical Sleep Medicine (2017) DOI: 10.5664/jcsm.6470

Insomnia - Overview and Facts - (http://www.sleepeducation.org/essentials-in-sleep/insomnia)

Source-Medindia